Northern Technologies International Earnings Calls
| Release date | Jul 09, 2026 |
| EPS estimate | $0.0400 |
| EPS actual | -$0.0200 |
| EPS Surprise | -150.00% |
| Revenue estimate | 23.4M |
| Revenue actual | 24.216M |
| Revenue Surprise | 3.49% |
| Release date | Apr 09, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0100 |
| EPS Surprise | -50.00% |
| Revenue estimate | 21.1M |
| Revenue actual | 21.997M |
| Revenue Surprise | 4.25% |
| Release date | Jan 08, 2026 |
| EPS estimate | $0.0500 |
| EPS actual | $0.0400 |
| EPS Surprise | -20.00% |
| Revenue estimate | 22.1M |
| Revenue actual | 23.309M |
| Revenue Surprise | 5.47% |
| Release date | Nov 18, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | -$0.0600 |
| EPS Surprise | -175.00% |
| Revenue estimate | 22.4M |
| Revenue actual | 22.315M |
| Revenue Surprise | -0.377% |
Last 4 Quarters for Northern Technologies International
Below you can see how NTIC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 18, 2025 |
| Price on release | $7.48 |
| EPS estimate | $0.0800 |
| EPS actual | -$0.0600 |
| EPS surprise | -175.00% |
| Date | Price |
|---|---|
| Nov 12, 2025 | $8.14 |
| Nov 13, 2025 | $8.06 |
| Nov 14, 2025 | $8.06 |
| Nov 17, 2025 | $7.95 |
| Nov 18, 2025 | $7.48 |
| Nov 19, 2025 | $7.44 |
| Nov 20, 2025 | $7.52 |
| Nov 21, 2025 | $7.53 |
| Nov 24, 2025 | $7.48 |
| 4 days before | -8.11% |
| 4 days after | 0% |
| On release day | -0.535% |
| Change in period | -8.11% |
| Release date | Jan 08, 2026 |
| Price on release | $8.69 |
| EPS estimate | $0.0500 |
| EPS actual | $0.0400 |
| EPS surprise | -20.00% |
| Date | Price |
|---|---|
| Jan 02, 2026 | $8.12 |
| Jan 05, 2026 | $8.66 |
| Jan 06, 2026 | $8.91 |
| Jan 07, 2026 | $8.74 |
| Jan 08, 2026 | $8.69 |
| Jan 09, 2026 | $8.75 |
| Jan 12, 2026 | $9.21 |
| Jan 13, 2026 | $8.96 |
| Jan 14, 2026 | $9.56 |
| 4 days before | 7.02% |
| 4 days after | 10.01% |
| On release day | 0.633% |
| Change in period | 17.73% |
| Release date | Apr 09, 2026 |
| Price on release | $8.01 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0100 |
| EPS surprise | -50.00% |
| Date | Price |
|---|---|
| Apr 02, 2026 | $7.92 |
| Apr 06, 2026 | $8.10 |
| Apr 07, 2026 | $8.10 |
| Apr 08, 2026 | $8.00 |
| Apr 09, 2026 | $8.01 |
| Apr 10, 2026 | $8.00 |
| Apr 13, 2026 | $8.11 |
| Apr 14, 2026 | $8.05 |
| Apr 15, 2026 | $8.08 |
| 4 days before | 1.14% |
| 4 days after | 0.87% |
| On release day | -0.125% |
| Change in period | 2.02% |
| Release date | Jul 09, 2026 |
| Price on release | $8.26 |
| EPS estimate | $0.0400 |
| EPS actual | -$0.0200 |
| EPS surprise | -150.00% |
| Date | Price |
|---|---|
| Jul 02, 2026 | $8.63 |
| Jul 06, 2026 | $8.86 |
| Jul 07, 2026 | $8.80 |
| Jul 08, 2026 | $8.58 |
| Jul 09, 2026 | $8.26 |
| Jul 10, 2026 | $8.15 |
| Jul 13, 2026 | $8.10 |
| 4 days before | -4.29% |
| 4 days after | -1.94% |
| On release day | -1.33% |
| Change in period | -6.14% |
Northern Technologies International Earnings Call Transcript Summary of Q2 2026
NTIC reported solid Q2 FY2026 results with consolidated net sales up 15.3% year-over-year to $22.0M. Key drivers were record ZERUST Oil & Gas sales (up 72.1%) — including a three-year, ~$13M offshore contract — stronger China performance (NTIC China sales +18.5%), and Natur‑Tec bioplastics growth (+8.1%). Joint venture sales (not consolidated) rose 18.6% and joint venture operating income increased ~19.8%. Gross margin was stable (35.7%) and non‑GAAP adjusted net income was $70K ($0.01/sh), while GAAP net loss was $35K. Operating expenses rose modestly but decreased as a percentage of sales (43.2% vs 46.2% prior year). Balance sheet highlights: working capital $20.2M, cash $5.6M, and debt $14.3M (including $11.3M on the revolver). Management reiterated expectation for continued sales growth and improved profitability in FY2026 driven by oil & gas, China, and Natur‑Tec, and emphasized focus on operating leverage, working capital efficiencies and debt reduction. Key risks remain: geopolitical uncertainty (Middle East war), supply chain and raw‑material price volatility, European softness impacting certain joint ventures (Germany), and margin variability in Natur‑Tec due to input prices, tariffs and competitive pricing.
Sign In
Buy NTIC